spacer
home > ebr > summer 2003 > spr-ms in functional proteomics
PUBLICATIONS
European Biopharmaceutical Review

SPR-MS in Functional Proteomics

As the advent of proteomics switches the emphasis from genes to proteins, increased scientific attention is being paid to techniques that produce detailed information on human proteins. Much interest has been concentrated on identification and structural characterisation of the proteins in a cell, using techniques such as mass spectrometry (MS). The true value of genomic information however, will only be realised when this data is combined with functional characterisation of the proteins in question, using techniques such as surface plasmon resonance (SPR). It is not often that two analytical techniques can be successfully combined to correlate data, whilst simultaneously increasing the quality and quantity of output - but this is the case with SPR and MS.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Stefan Löfås, Vice President and Chief Scientific Officer at Biacore AB

Dr Stefan Löfås holds a PhD and BSc in Organic Chemistry. He has gained extensive technical and scientific experience in the development and commercialisation of bioanalytical instrumentation at Biacore AB, having worked for the company since 1985. He has been deeply involved in the development of Biacore's sensor chip chemistry and applications. He was recently appointed Chief Scientific Officer with responsibility for technical development projects, external scientific collaborations and technical aspects on IPR portfolio. Prior to this, Dr Löfås was Director of Biacore's biochemistry & chemistry department within R&D.

spacer
Dr Stefan Löfås
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2019

PPMA Group is today issuing a ‘Final Call for Entries’ to the 2019 PPMA Group Industry Awards. All companies within the packaging and processing sector are invited to submit their FREE submission by the deadline of 17 July 2019.
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement